Our results suggest that Tv1 inhibits HCC selectively and that its mechanism of action involves downstream manipulation of TRPC6 and/or TRPV6 channel activity, which were overexpressed in the HCC models used in this study. Here, TRPC6 is linked to hepatocellular carcinoma.